Study design
macrosomia, GDM
GDM, POSTPARTUM HEMORRHAGE, NEONATAL ASPHYXIA, GESTATIONAL HYPERTENSION
We conducted this RCT at Beijing Obstetrics and Gynecology Hospital, Capital Medical University. The participants were recruited from March, 2021 to December, 2021. The participants were randomly assigned to either the intervention group or the control group. Primary outcome is CS rate. Secondary outcomes are gestational hypertension, preeclampsia and eclampsia, GDM, postpartum hemorrhage, neonatal asphyxia, and macrosomia. The trial register number is ChiCTR2300068845 (01/03/2023).